Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
about
Prevention of fatal opioid overdoseWorldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the LiteratureOpioid overdose prevention and naloxone rescue kits: what we know and what we don't knowOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisIntertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery.Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids.Two cases of intranasal naloxone self-administration in opioid overdose.Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample.Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program.Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugsFlumazenil, naloxone and the 'coma cocktail'.High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid usersReductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation.Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.The benefits and potential drawbacks in the approval of EVZIO for lay reversal of opioid overdoseOverdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.Opioid education and nasal naloxone rescue kits in the emergency departmentTake-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland's public health policy evaluation, and a new measure to assess impactMessaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey ExperimentHeroin-related overdose: The unexplored influences of markets, marketing and source-types in the United StatesA Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak.Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for interventionOrienting patients to greater opioid safety: models of community pharmacy-based naloxone.Distribution of naloxone for overdose prevention to chronic pain patients.Correlates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care StaffWhy the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, CanadaTrends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009.New Perspectives in the Treatment of Opioid-Induced Respiratory Depression.An Evaluation of Naloxone Use for Opioid Overdoses in West Virginia: A Literature ReviewInjection drug users trained by overdose prevention programs: responses to witnessed overdoses.Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients.Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose.Overdose Education and Naloxone Rescue Kits for Family Members of Individuals Who Use Opioids: Characteristics, Motivations, and Naloxone Use.A decline in the prevalence of injecting drug users in Estonia, 2005-2009.Between harm reduction, loss and wellness: on the occupational hazards of work
P2860
Q24631270-DFDE6C18-A58D-4AC4-8604-FDF905C52ABCQ26785445-FD432848-2BDF-4122-AA18-386C16537B68Q28365114-26344893-E0C2-4CFB-A92C-5EA2633D1F5AQ28397248-AAE183F8-BF36-416F-90B4-68CE379372B4Q28486015-F7168932-6F31-4A2A-B4F3-D1C3CB50CF55Q30654725-5FACD604-FDAA-4CA6-BC8F-1DB96D6AD9CBQ30816828-ABDD5798-BF22-440B-A16C-74A646D829CEQ33606282-20F28D89-483A-4BF0-AD3D-1706CB600018Q33613641-081120D8-49F3-4C8A-A5C5-5D1A52D97D42Q33691974-1D502E82-5C84-4578-BCD2-CEBB26FFCA75Q34280151-4180194B-E4B6-42B0-B418-774A3617602DQ34287159-2E03E766-AE8E-4D0D-81F1-398F36C94A15Q34498099-259489A5-1F23-461C-80C1-AE58CB55479BQ34778050-ECA44B8A-B6F7-4879-AAB7-308CC558FDABQ34808676-00D25F36-4EF4-40D8-93F7-3BB4B38FAB93Q35019475-6E811219-BD44-452F-8E65-762677EEFD71Q35117913-418C3872-0164-4C2F-9483-EA50E5FE4C68Q35135608-38792919-6737-4913-A2EB-BF35F6A465EAQ35592699-2BCA298F-2932-4975-8E35-C908BB34AA93Q35626439-1629AE9E-65F8-4E69-9B0A-420CB5875737Q35680274-1A1AAAE4-A17D-46A4-B8C5-0D7546D00CF4Q35707238-CBD34429-37B2-4782-B69F-7EC4E90E4013Q35751870-E15831EC-2B24-40E5-A396-D6C197B0CED6Q35832577-E6F1BD54-2933-4422-8558-D2BB3F69D59EQ35855231-926B9DC5-A13A-4930-B83D-14B2BC1C2DE8Q35882669-50D20FF8-2D8E-452D-AA48-E1C209F9E306Q35923351-289649FB-35D0-40FF-B13E-34FE53557AA4Q36117657-E0E6FAD6-83E2-4899-AFE6-10291978E317Q36163633-2606F107-95D2-40EA-A897-635CBA8A3D80Q36258402-E641B9A7-42CA-4EBC-BA5C-ABBAB3DE32D0Q36294363-413532C4-79E9-4185-B1C8-D2ADC19C2B4CQ36319074-B1DFBA4F-1ACF-4034-B312-8C15D257F743Q36333862-D9B7A3F1-764B-41F1-AECA-89327E71C51FQ36362393-D0F5915D-3198-4DA6-9CA4-5A75BE9A8DAAQ36451555-E6E1A0D0-ACFA-4841-B320-E9329150B5BBQ36554504-7AA684F3-DE57-445F-9B6E-A7031CB29C6AQ36726275-B4403D14-4A64-4397-AD78-4740D70FB743Q36733605-13AD6343-E549-463D-871E-CF4790E22B5AQ36803801-BD8B0CA0-72B0-4371-9540-6CDFB72AD2DFQ36843335-B9D52226-849C-4B8D-BCB0-C85E779C3DBA
P2860
Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Community-based opioid overdos ...... aloxone - United States, 2010.
@ast
Community-based opioid overdos ...... aloxone - United States, 2010.
@en
Community-based opioid overdos ...... aloxone - United States, 2010.
@nl
type
label
Community-based opioid overdos ...... aloxone - United States, 2010.
@ast
Community-based opioid overdos ...... aloxone - United States, 2010.
@en
Community-based opioid overdos ...... aloxone - United States, 2010.
@nl
prefLabel
Community-based opioid overdos ...... aloxone - United States, 2010.
@ast
Community-based opioid overdos ...... aloxone - United States, 2010.
@en
Community-based opioid overdos ...... aloxone - United States, 2010.
@nl
P2860
P1476
Community-based opioid overdos ...... naloxone - United States, 2010
@en
P2860
P304
P577
2012-02-01T00:00:00Z